Accessibility Information and Accesskeys | Skip navigation

Novel Drug for high dose radiation

A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D., from the University of Tennessee Health Science Center and Baylor College of Medicine, show that application of this drug, starting 24 hours after radiation exposure, increases survival in animal models by three-fold compared to placebo.

Their work, which is funded through an NIH grant from the National Institute for Allergy and Infectious Diseases, is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Chicago, Ill., Oct. 14 - 18.

"Development of drugs for individuals who are exposed to high-dose radiation in a public health emergency has been a priority since the 9/11 terrorist attacks," said Yates. "The ultimate goal is wide dissemination of non-invasive treatments after 24 hours of a mass casualty."

The rest of the article can be read by following the link below.

Ionactive Comment

It is wrong advertise the worth of such a drug, which may have genuine uses, by using 9/11 and other similar real or potential terrorist events (e.g. a “Dirty Bomb” – radiological dispersal device). In the most credible scenario, deterministic levels of radiation exposure that would lead to radiation sickness (and for which these new drugs might help) is just not going to happen.

Article Source:

The rest of the article can be read at the following link: Novel drug increases survival in animal models exposed to high-dose radiation.

Back to previous page